Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance
Open Access
- 25 June 2026
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 45 (15-17) , e70650
Abstract
Comparing future antibiotic resistance levels resulting from different antibiotic treatments is challenging because some patients may survive only under one of the antibiotic treatments. We embed this problem within a semi‐competing risks approach to study the causal effect on resistant infection, treated as a nonterminal event time. We argue that existing principal stratification estimands for such problems exclude patients for whom a causal effect is well‐defined and is of clinical interest. Therefore, we present a new principal stratum, the infected‐or‐survivors (). The is the subpopulation of patients who would have survived or been infected under both antibiotic treatments. This subpopulation is more inclusive than previously defined subpopulations. We target the causal effect among these patients, which we term the feasible‐infection causal effect (FICE). We develop large‐sample bounds under novel assumptions, and discuss the plausibility of these assumptions in our application. As an alternative, we derive FICE identification using two illness‐death models with a bivariate frailty random variable. These two models are connected by a cross‐world correlation parameter. Estimation is performed by an expectation‐maximization algorithm followed by a Monte Carlo procedure. We apply our methods to detailed clinical data obtained from a hospital setting.Keywords
All Related Versions
Funding Information
- Israel Science Foundation (827/21)
- Israel Science Foundation (1286/21)
This publication has 39 references indexed in Scilit:
- Survivor Average Causal Effects for Continuous Time: A Principal Stratification Approach to Causal Inference With Semicompeting RisksBiometrical Journal, 2025
- Penicillin allergy as an instrumental variable for estimating antibiotic effects on resistanceNature Communications, 2025
- The scope of the antimicrobial resistance challengeThe Lancet, 2024
- Multistate models as a framework for estimand specification in clinical trials of complex processesStatistics in Medicine, 2023
- The time-varying association between previous antibiotic use and antibiotic resistanceClinical Microbiology and Infection, 2022
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Emergence and dissemination of antimicrobial resistance in Escherichia coli causing bloodstream infections in Norway in 2002–17: a nationwide, longitudinal, microbial population genomic studyThe Lancet Microbe, 2021
- A causal framework for classical statistical estimands in failure‐time settings with competing eventsStatistics in Medicine, 2020
- Regression analysis based on conditional likelihood approach under semi-competing risks dataLifetime Data Analysis, 2012
- Estimating causal effects of treatments in randomized and nonrandomized studies.Journal of Educational Psychology, 1974